(MedPage Today) -- When I first read about the Samantha Fulnecky and Mel Curth debacle that captivated the nation last week, I thought: "Well that's the most creative grade negotiation...

(MedPage Today) -- Florida officials are plowing ahead with a proposal to roll back certain vaccine mandates for the state's schoolchildren, after Republican Gov. Ron DeSantis called for the state...

(MedPage Today) -- Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2...

EPASir Keir Starmer has urged resident doctors not to go ahead with "reckless" strikes planned for next week, saying it is "beyond belief" they could take place during a flu...

James Gallagher,Health and science correspondentandCatherine Snowdon,Health reporterGettySome men are having vast numbers of children through sperm donation. This week the BBC reported on a man whose sperm contained a genetic...

(MedPage Today) -- More than a third of resuscitated infants born alive at 21 weeks' gestational age -- an age previously believed to be previable -- survived to discharge, a...

(MedPage Today) -- COVID vaccines for the 2024-2025 season provided protection against COVID-associated emergency department (ED) and urgent care visits among children, according to data from a multisite electronic health...

(MedPage Today) -- Andexanet alfa (Andexxa) will officially be taken off the U.S. market this month as an emergency reversal medication for contemporary blood thinners. "The Biologics License Application for...

(MedPage Today) -- SAN ANTONIO -- Risk-based breast cancer screening proved noninferior for detecting clinically significant tumors in a randomized trial, though outside experts raised concerns and a major medical...

(MedPage Today) -- Several insurers are automatically downcoding -- and, therefore, paying less for -- claims for non-procedural office visits, a practice that provider groups said is unfair and may...

(MedPage Today) -- The FDA expanded the indication of inebilizumab (Uplizna) to include generalized myasthenia gravis (gMG), Amgen announced Friday. The drug is now approved to treat gMG in adults...

Katy WatsonAustralia correspondent , PerthGetty ImagesCritics say gaming platforms should be included in Australia's ban on social media for under-16sWednesday afternoons have become a ritual for 15-year-old Sadmir Perviz. It's...

(MedPage Today) -- King Charles III shared a personal message about his experience with cancer and encouraged others to get screened in a prerecorded video message airing on British television....

(MedPage Today) -- Last week, FDA Commissioner Marty Makary, MD, MPH, announced plans to officially lower the standard for how many clinical trials are needed to approve a new drug...

(MedPage Today) -- SAN ANTONIO -- Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested. After 5 years,...

(MedPage Today) -- In a late-night keyboard marathon this week, President Donald Trump fired off a post on Truth Social announcing he "aced" his third cognitive test. "In addition to...

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with existing therapies. Medscape Medical News Source link : https://www.medscape.com/viewarticle/mounjaro-cleared-type-2-diabetes-eu-children-2025a1000yz4?src=rss Author : Publish...

(MedPage Today) -- Clinicians face exciting new options in immunoglobulin A (IgA) nephropathy, with recent accelerated FDA approvals and positive data presented on agents targeting B-cell activating factor (BAFF) and...

Trial results showed improvements in symptoms, exercise capacity, and left ventricular outflow obstruction. Medscape Medical News Source link : https://www.medscape.com/viewarticle/targeted-therapy-nears-eu-approval-obstructive-hcm-2025a1000yz1?src=rss Author : Publish date : 2025-12-12 17:13:00 Copyright for syndicated...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a positive benefit-risk balance. Medscape News Europe Source link : https://www.medscape.com/viewarticle/ema-rejects-alzheimers-drug-after-trial-falls-short-2025a1000yz0?src=rss Author...